Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9325275 | Fertility and Sterility | 2005 | 5 Pages |
Abstract
The use of GnRH antagonist rather than agonist cotreatment during ovarian hyperstimulation for IVF is not widely accepted. Possible benefits, current shortcomings, and avenues for future development are discussed.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Bart C.J.M. M.D., Paul M.D.,